Various pharmaceutical products / 2024-2025

Description du marché

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Morphine 10-20 mg/ml (1-5 ml per vial/ampoule, i.m., ATC N02AA01) - Intramuscular administration - Active pharmaceutical ingredient: Morphine - Strength: 10-20 mg/ml - Pharmaceutical form: 1-5 ml per vial/ampoule The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the articles is described in Annex 1. Estimated quantity for the Article is described in Annex 6 (restricted, TL IV). In addition to the estimated quantity indicated in the Annex 6, the Customer is entitled to purchase 100 % extra to the estimated quantities (later referred as "Option"). The Customer can use as much of the option as it needs. The Customer shall notify the Supplier by the end of June 2026 at the latest, if it wishes to exercise the Option. The delivery schedule for the Option will be agreed separately between the Contracting parties. The Supplier is not obliged to deliver the Articles under the Option. The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.

Pouvoir adjudicateur